235 related articles for article (PubMed ID: 22057994)
1. Association between interleukin 21 and Graves' disease.
Jia HY; Zhang ZG; Gu XJ; Guo T; Cui B; Ning G; Zhao YJ
Genet Mol Res; 2011 Oct; 10(4):3338-46. PubMed ID: 22057994
[TBL] [Abstract][Full Text] [Related]
2. Association of the interleukin (IL)-16 gene polymorphisms with Graves' disease.
Gu XJ; Cui B; Zhao ZF; Chen HY; Li XY; Wang S; Ning G; Zhao YJ
Clin Immunol; 2008 Jun; 127(3):298-302. PubMed ID: 18394967
[TBL] [Abstract][Full Text] [Related]
3. Association studies of interleukin-8 gene in Graves' disease and Graves' ophthalmopathy.
Gu LQ; Jia HY; Zhao YJ; Liu N; Wang S; Cui B; Ning G
Endocrine; 2009 Dec; 36(3):452-6. PubMed ID: 19816813
[TBL] [Abstract][Full Text] [Related]
4. CTLA4 polymorphisms and ophthalmopathy in Graves' disease patients: association study and meta-analysis.
Han S; Zhang S; Zhang W; Li R; Li Y; Wang Z; Xie Y; Mao Y
Hum Immunol; 2006 Aug; 67(8):618-26. PubMed ID: 16916658
[TBL] [Abstract][Full Text] [Related]
5. Polymorphisms in the interleukin 3 gene show strong association with susceptibility to Graves' disease in Chinese population.
Chu X; Dong C; Lei R; Sun L; Wang Z; Dong Y; Shen M; Wang Y; Wang B; Zhang K; Yang L; Li Y; Yuan W; Wang Y; Song H; Jin L; Xiong M; Huang W
Genes Immun; 2009 Apr; 10(3):260-6. PubMed ID: 19262575
[TBL] [Abstract][Full Text] [Related]
6.
Zhang M; Liu S; Xu J; Lv S; Fan Y; Zhang Y; Zhang Y; Wu Y; Su Y; Yu H; Song S; He J; Li H
Curr Eye Res; 2020 Jul; 45(7):888-895. PubMed ID: 31869260
[TBL] [Abstract][Full Text] [Related]
7. Polymorphisms of endothelin 1 (G5665T and T-1370G) and endothelin receptor type A (C+70G and G-231A) in Graves' disease.
Aydın AF; Develi-İş S; Doğru-Abbasoğlu S; Vural P; Ozderya A; Karadağ B; Uysal M
Int Immunopharmacol; 2014 Jan; 18(1):198-202. PubMed ID: 24291390
[TBL] [Abstract][Full Text] [Related]
8. Lymphoid tyrosine phosphatase (PTPN22/LYP) variant and Graves' disease in a Polish population: association and gene dose-dependent correlation with age of onset.
Skórka A; Bednarczuk T; Bar-Andziak E; Nauman J; Ploski R
Clin Endocrinol (Oxf); 2005 Jun; 62(6):679-82. PubMed ID: 15943829
[TBL] [Abstract][Full Text] [Related]
9. Association analysis of polymorphisms in IL-3, IL-4, IL-5, IL-9, and IL-13 with Graves' disease.
Zhu W; Liu N; Zhao Y; Jia H; Cui B; Ning G
J Endocrinol Invest; 2010 Nov; 33(10):751-5. PubMed ID: 20332709
[TBL] [Abstract][Full Text] [Related]
10. The common variants of E-selectin gene in Graves' disease.
Chen H; Cui B; Wang S; Zhao Z; Sun H; Gu X; Zhao Y; Li X; Ning G
Genes Immun; 2008 Mar; 9(2):182-6. PubMed ID: 18094708
[TBL] [Abstract][Full Text] [Related]
11. Associations of protein tyrosine phosphatase nonreceptor 22 (PTPN22) gene polymorphisms with susceptibility to Graves' disease in a Japanese population.
Ichimura M; Kaku H; Fukutani T; Koga H; Mukai T; Miyake I; Yamada K; Koda Y; Hiromatsu Y
Thyroid; 2008 Jun; 18(6):625-30. PubMed ID: 18578611
[TBL] [Abstract][Full Text] [Related]
12. Association of an IL-4 gene haplotype with Graves disease in children: experimental study and meta-analysis.
Lee YJ; Huang CY; Ting WH; Lee HC; Guo WL; Chen WF; Lin CL; Liu HF; Lin M; Lo FS
Hum Immunol; 2011 Mar; 72(3):256-61. PubMed ID: 21195738
[TBL] [Abstract][Full Text] [Related]
13. Use of Tag single nucleotide polymorphisms (SNPs) to screen PTPN21: no association with Graves' disease.
Zeitlin AA; Heward JM; Brand OJ; Newby PR; Franklyn JA; Gough SC; Simmonds MJ
Clin Endocrinol (Oxf); 2006 Sep; 65(3):380-4. PubMed ID: 16918960
[TBL] [Abstract][Full Text] [Related]
14. Clinical associations of the genetic variants of CTLA-4, Tg, TSHR, PTPN22, PTPN12 and FCRL3 in patients with Graves' disease.
Gu LQ; Zhu W; Zhao SX; Zhao L; Zhang MJ; Cui B; Song HD; Ning G; Zhao YJ
Clin Endocrinol (Oxf); 2010 Feb; 72(2):248-55. PubMed ID: 19438904
[TBL] [Abstract][Full Text] [Related]
15. Association study between methylenetetrahydrofolate reductase gene polymorphisms and Graves' disease.
Mao R; Fan Y; Zuo L; Geng D; Meng F; Zhu J; Li Q; Qiao H; Jin Y; Bai J; Fu S
Cell Biochem Funct; 2010 Oct; 28(7):585-90. PubMed ID: 20941748
[TBL] [Abstract][Full Text] [Related]
16. Vascular endothelial growth factor polymorphisms increase the risk of developing Graves' disease.
Vural P; Baki M; Doğru-Abbasoğlu S; Özderya A; Karadağ B; Uysal M
Int Immunopharmacol; 2012 Oct; 14(2):133-7. PubMed ID: 22771446
[TBL] [Abstract][Full Text] [Related]
17. A variant of the Il2ra / Cd25 gene predisposing to graves' disease is associated with increased levels of soluble interleukin-2 receptor.
Chistiakov DA; Chistiakova EI; Voronova NV; Turakulov RI; Savost'anov KV
Scand J Immunol; 2011 Nov; 74(5):496-501. PubMed ID: 21815908
[TBL] [Abstract][Full Text] [Related]
18. Association of NFKB1 -94ins/del ATTG promoter polymorphism with susceptibility to and phenotype of Graves' disease.
Kurylowicz A; Hiromatsu Y; Jurecka-Lubieniecka B; Kula D; Kowalska M; Ichimura M; Koga H; Kaku H; Bar-Andziak E; Nauman J; Jarzab B; Ploski R; Bednarczuk T
Genes Immun; 2007 Oct; 8(7):532-8. PubMed ID: 17690684
[TBL] [Abstract][Full Text] [Related]
19. Lack of association of interleukin-18 gene polymorphisms with susceptibility of Japanese populations to Graves' disease or Graves' ophthalmopathy.
Mukai T; Hiromatsu Y; Ichimura M; Fukutani T; Kaku H; Miyake I; Shoji S; Koda Y; Bednarczuk T
Thyroid; 2006 Mar; 16(3):243-8. PubMed ID: 16571086
[TBL] [Abstract][Full Text] [Related]
20. Pretibial myxedema is associated with polymorphism in exon 1 of CTLA-4 gene in patients with Graves' ophthalmopathy.
Khalilzadeh O; Mojazi Amiri H; Tahvildari M; Anvari M; Esteghamati A; Mobarra Z; Tehranchinia Z; Rashidi A; Amirzargar A
Arch Dermatol Res; 2009 Oct; 301(10):719-23. PubMed ID: 19037649
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
